Objective-ATP-binding cassette transporter A1 (ABCA1) is thought to lipidate apolipoprotein A-I (apoA-I) at the plasma membrane, with endosomal cholesterol contributing as substrate. The mechanisms of ABCA1 surface delivery are not well understood. We have shown that Rab8 regulates endosomal cholesterol removal to apoA-I in human fibroblasts.
D uring the formation of an atherosclerotic plaque, monocyte-derived macrophages invade the arterial wall where they scavenge lipoprotein particles retained in the intima. This results in excessive cholesterol deposition in the macrophages that transform into lipid-laden foam cells. The internalized cholesterol in turn elicits adaptive responses, such as activation of cholesterol storage and removal systems. 1 Efflux of cholesterol from macrophage foam cells to apolipoprotein A-I (apoA-I), the major apolipoprotein of high-density lipoprotein (HDL), is thought to represent a critical step in macrophage reverse cholesterol transport 2 and one of the key mechanisms in the antiatherogenic action of HDL. 3 Lipid-poor apoA-I interacts with the ATP-binding cassette (ABC) transporter A1 (ABCA1) on the cell surface to promote net cholesterol efflux to apoA-I. 4 In macrophages lacking ABCA1 function, cholesterol and phospholipid efflux to apoA-I is severely attenuated, and massive amounts of cholesterol are stored as fatty acid esters in lipid droplets. 5, 6 In comparison to the plasma membrane events in cholesterol efflux, the intracellular mechanisms that govern ABCA1 trafficking to the cell surface and cholesterol delivery for efflux are poorly understood. Endosomal compartments are apparently involved. There is evidence that acetylated LDL (acLDL)-derived cholesterol deposited in late endosomes/lysosomes is a significant source of cholesterol for ABCA1mediated cholesterol efflux. 7 Deletion of the PEST sequence of ABCA1 impaired its transport to late endosomes and consequently reduced the efflux of acLDL-derived cholesterol to apoA-I. 8 Moreover, we found that in human fibroblasts the delivery of cholesterol from late endosomal compartments to apoA-I was stimulated on overexpression of the small GTPase Rab8. 9 Rab8 belongs to the large family of Rab GTPases that regulate various stages of vesicular transport or membranecytoskeleton interactions. 10 So far, no Rabs have been reported as regulators of macrophage cholesterol trafficking. In earlier studies, Rab8 has been implicated in cytoskeletal organization and membrane trafficking to the cell surface, [11] [12] [13] including specialized plasma membrane domains. 14 -17 We therefore considered that Rab8 might also be involved in regulating the delivery of cholesterol via ABCA1 to apoA-I in human monocyte-derived macrophages. In this work, we studied the expression of Rab8 in macrophages and analyzed the effects of altered Rab8 expression on ABCA1 localization and macrophage cholesterol processing.
Methods
A detailed Materials and Methods section is posted as an online supplement (available at http://atvb.ahajournals.org).
Isolation of Primary Human Macrophages
Human monocytes from healthy control subjects were isolated from buffy coat cells (Finnish Red Cross Blood Transfusion Service) as described. 18 Monocytes were allowed to adhere to the flask for 60 minutes in RPMI medium, washed once with PBS, and differentiated into macrophages for 7 days in macrophage serum free medium (M-SFM) supplemented with 100U/mL penicillin, 100 g/mL streptomycin, and 10 ng/mL GM-CSF.
RNA Interference and Cholesterol Measurements in Primary Human Macrophages
Control and Rab8A-specific small interfering RNAs (siRNA) have been described. 12 SiRNA targeting human Rab8b was from Ambion (predesigned Silencer oligo 24779). On day 0, differentiated macrophages were collected by trypsinization and electroporated with control, Rab8A-, or Rab8b-specific siRNA using Human macrophage nucleofection kit (Amaxa). After electroporation, cells were incubated in M-SFM ϩ10% FBS for 18 hours, and on day 1 the medium was changed to M-SFM only. On day 2, the cells were loaded with 50 g/mL acLDL for 24 hours and incubated with 10 g/mL apoA-I for 18 hours. Cells were harvested in 1% Nonidet P-40 in PBS, and protein concentration was determined using the DC Protein Assay (Bio-Rad). Cholesterol amounts were measured using the Amplex Red Cholesterol Assay Kit (Invitrogen). For measurement of total [ 3 H]-cholesterol, equal amounts of material (corrected for protein amounts) was counted by liquid scintillation counting. Because of considerable variation in acLDL uptake between macrophages from different donors, values were normalized to those of acLDL-loaded control siRNA transfected cells.
Surface Biotinylation
Differentiated macrophages were electroporated as above. On day 2, the cells were incubated with 50 g/mL acLDL and 10 g/mL apoA-I for 24 hours. Surface biotinylation was carried out as described 19 except that EZ-Link Sulfo-NHS-SS-Biotin (Pierce) was used. One-tenth of the volume was removed to represent the "total" sample and 9/10 was precipitated with Streptavidin-agarose (Pierce) overnight at 4°C, followed by washes (once with lysis buffer, 3 times with 1% NP40 in PBS, twice in 0.1% NP40, 0.5 mol/L NaCl in PBS, twice with 50 mmol/L Tris-HCl, pH 7.5), and Western blotting. The fraction of ABCA1 on the cell surface was calculated by comparing the total versus biotinylated ABCA1 for each donor. To allow for comparison between macrophages from individual donors, the fraction of ABCA1 on the cell surface in control siRNA treated cells was set as 1.0.
Results

Rab8 Is Abundantly Expressed in Human Atherosclerotic Lesional Macrophages
To assess Rab8 expression in a physiological setting of foam cell formation, we stained sections of atheromatous human coronary arteries with anti-Rab8 antibodies. Marked Rab8 immunoreactivity was observed in the arterial intima, including cells with macrophage-like morphology that infiltrated the atheroma plaque. Prominent Rab8 immunoreactivity was observed in the cytoplasm, in particular in cells surrounding the necrotic lipid core ( Figure 1A and 1C ). Costaining with anti-CD68 antibody demonstrated significant overlap with anti-Rab8 immunostaining ( Figure 1B) , indicating that the highly Rab8 positive cells were indeed macrophages.
Lipid-Loaded Macrophages Target Rab8 and Cholesterol to the Leading Edge
To elucidate the role of Rab8 in macrophages, we studied its expression levels and localization. Human peripheral blood monocytes were differentiated into macrophages in vitro and loaded with acLDL to induce foam cell formation. When the expression levels of Rab8 were analyzed by Western blotting, we found Rab8 to be upregulated by approximately 2-fold on acLDL loading and to be downregulated after lipid unloading with apoA-I ( Figure 2A ).
The monocyte-derived macrophages underwent marked morphological changes on challenging with acLDL and apoA-I. The cells extended cholesterol-rich protrusions as identified by filipin staining (Figure 2B and 2D) and elongated ( Figure 2C ). This phenotype could also be achieved by incubating macrophages with acLDL or apoA-I alone ( Figure  2C ). Indeed, modified LDL is known to stimulate macrophage migration. 20 Motile cells are characteristically asymmetrical, with a retractile tail and a leading edge that harbors lamellipodial and filopodial extensions and cholesterol-rich membrane microdomains. 21 Rab8 has been localized to the perinuclear Golgi and recycling endosome compartments as well as to the plasma membrane. 12, 22 We found that in macrophages, acLDL and apoA-I induced the formation of lamellipodia and membrane ruffles that harbored considerable amounts of Rab8 as detected by immunostaining of the endogenous protein ( Figure 2D ).
Rab8 Overexpression Increases ABCA1 Levels and Reduces Cholesterol Deposition in Foam Cells
Rab8 overexpression is known to induce the formation of cell protrusions. 13 We therefore generated recombinant adenoviruses expressing Rab8A or an irrelevant protein (GFP) as a control. A 3-day infection of primary human macrophages with the Rab8 adenovirus resulted in pronounced overexpression of the protein ( Figure 3A ). Rab8 overexpression induced the formation of lamellipodia-like protrusions, similarly as incubation with apoA-I and acLDL, except that the phenotype was more exaggerated, with multiple extensions pointing to several directions (data not shown). Moreover, when the cellular ABCA1 amounts were analyzed, we observed a striking increase in ABCA1 levels in the Rab8-virus infected cells as compared to GFP-virus infected cells ( Figure 3B ). To determine whether this was attributable to increased ABCA1 gene transcription we performed quantitative real-time PCR on control or Rab8 infected macrophages. The ABCA1 mRNA levels were not altered, suggesting that the half-life of the ABCA1 protein is increased in Rab8 overexpressing cells ( Figure 3C ).
To study the effect of Rab8 overexpression on ABCA1dependent cholesterol efflux, we measured the efflux of [ 3 H]-cholesterol from infected macrophages to apoA-I. Rab8 overexpression increased [ 3 H]-cholesterol efflux to apoA-I by Ϸ20% as compared to control ( Figure 3D ). To assess the effect of Rab8 overexpression on foam cell cholesterol processing, the adenovirally infected cells were loaded overnight with acLDL in the presence of apoA-I. The amount of cholesterol deposited in the cells was then determined. In control adenovirus infected cells, the total cholesterol levels increased about 1.7-fold during this treatment. We found that the Rab8-overexpressing cells accumulated slightly less cholesterol than the control infected cells despite the continuous cholesterol challenge ( Figure 3E ). In this setting, Rab8 overexpression primarily affected the cholesteryl ester pool. The lipid challenge increased the cholesteryl ester stores of GFP-expressing cells about 8-fold, whereas in Rab8 overexpressing cells the cholesteryl ester stores increased only about 5-fold, ie, there was a Ϸ40% reduction in cholesteryl esters ( Figure 3F ).
Rab8 Depletion Aggravates Foam Cell Cholesterol Deposition and Inhibits Cholesterol Efflux to ApoA-I
Next, we depleted endogenous Rab8 from human primary macrophages using siRNAs. Rab8 antibodies visualized a doublet of bands at Ϸ25kDa in Western blots ( Figure 4A) , with the upper band corresponding to Rab8A and the lower to the Rab8b isoform. Specific siRNAs for separately knocking down each isoform were generated and introduced into differentiated macrophages for 2 days. This typically resulted in Ϸ70% depletion of the target protein isoform with no apparent change in the level of the other isoform ( Figure 4A) .
Rab8A siRNA or control siRNA-treated cells were loaded with acLDL overnight. In control siRNA-treated cells, this increased the total cellular cholesterol levels about 3-fold and the fraction of cholesteryl esters from Ϸ3.5% in the basal situation to Ϸ45% after acLDL loading. Rab8A-depleted cells were cholesterol loaded on acLDL incubation to a similar extent as the control cells ( Figure 4B ). Control and Rab8A siRNA-treated cells were then incubated in the presence of apoA-I overnight to induce net cholesterol efflux. In control siRNA-treated cells, a significant reduction in the total cholesterol level was achieved ( Figure 4B ). In contrast, there was essentially no reduction in the sterol levels of Rab8A siRNA-treated cells after the apoA-I incubation (Figure 4B) , and a major fraction of the sterol remained as fatty acid esters (Ϸ48% and Ϸ40% in Rab8A and control siRNA treated cells, respectively). In contrast, depletion of the Rab8b isoform did not affect cholesterol levels on acLDL loading or apoA-I efflux, and the combined effect of Rab8A and Rab8b depletion was not more pronounced than that obtained with Rab8A depletion alone (data not shown). Notably, also in other systems, differential roles for the Rab8A and Rab8b isoforms have been reported. 23, 24 Consequently, we next focused on the effects of Rab8A depletion.
To investigate whether the pool of cholesterol endocytosed via scavenging of modified lipoproteins represents a pool of cholesterol that is affected by Rab8 siRNAs, we loaded control or Rab8 siRNA treated cells with [ 3 H]-cholesteryl oleate labeled acLDL, followed by cholesterol efflux to apoA-I as described above. This radiolabeled cholesteryl ester pool is hydrolyzed by lysosomal acid lipase followed by transfer of free [ 3 H]-cholesterol to extracellular acceptors, and can therefore be used to trace cholesterol efflux from late endosomes. 8 We found that [ 3 H]-cholesteryl oleate loading of Rab8A siRNA-treated cells was comparable to that of control siRNA-treated cells but that the efflux of the [ 3 H]-cholesterol from Rab8-depleted cells was reduced as compared to the control cells ( Figure 4C and 4D ). This suggests that defective mobilization of the late endosomal cholesterol pool to apoA-I significantly contributes to the cholesterol deposition phenotype observed in Rab8-depleted macrophages.
Rab8 Depletion Reduces ABCA1 at the Plasma Membrane and Affects its Intracellular Routing
ABCA1-mediated lipidation of apoA-I is thought to take place at the plasma membrane. 4 Because Rab8 can regulate protein delivery to the cell surface, 22 we considered that Rab8 depletion might reduce cholesterol efflux to apoA-I by interfering with the cell surface exposure of ABCA1. To determine the amounts of ABCA1 at the plasma membrane, we performed surface biotinylation of Rab8 depleted and control macrophages followed by anti-ABCA1 Western blotting. This revealed a marked reduction in the fraction of ABCA1 protein at the plasma membrane in Rab8 knockdown cells ( Figure 5A and 5B) . To assess the effect of Rab8 siRNA on the subcellular localization of ABCA1, we studied the trafficking of ABCA1-GFP. Because we were not able to express ABCA1-GFP in primary human macrophages, the experiments were carried out in HeLa cells. We found that there was considerable colocalization between overexpressed ABCA1 and Rab8 in plasma membrane protrusions (supplemental Figure I) . Depletion of Rab8A from HeLa cells resulted in increased intracellular cholesterol deposition (supplemental Figure IIA and IIB), as previously shown for fibroblasts, 9 and decreased the plasma membrane expression of endogenous ABCA1 as assessed by surface biotinylation (data not shown). In control siRNA-treated cells ABCA1-GFP was targeted to cell surface protrusions with lamellipodial and ruffling membranes, where it colocalized with ␤1 integrin (supplemental Figure IIC, arrows; supplemental Figure III ). Rab8A knockdown cells were devoid of such surface protrusions; instead, prominent intracellular, ␤1 integrin, and ABCA1-GFP containing tubules were observed (supplemental Figures IIC and III) . This was paralleled by decreased ABCA1-GFP plasma membrane localization. ABCA1-GFP showed little colocalization with transferrin receptor (TfR) in control cells (supplemental Figures IID and IV) , in accordance with previous results. 25 In contrast, in about Ϸ50% of Rab8 knockdown cells ABCA1-GFP localized to perinuclear, TfR positive structures (supplemental Figure IID, arrows; supplemental Figure IV) . Together, these data suggest that the recycling of ABCA1-GFP is affected by Rab8 depletion.
Discussion
The present work identifies the first Rab GTPase that regulates the availability of ABCA1 at the plasma membrane in primary human macrophages. This is important for macrophage lipid processing because ABCA1 is active at the plasma membrane, and this activity is critical for the initiation of cholesterol removal from macrophage foam cells. 6 We show that depletion of Rab8 reduced the fraction of ABCA1 at the plasma membrane, and this was paralleled by decreased cholesterol efflux to apoA-I. In contrast, Rab8 overexpression increased ABCA1 levels and helped macrophages to resist cholesterol deposition when exposed to modified LDL. Because of these findings and the discovery that Rab8 was robustly expressed in macrophages of human atherosclerotic plaques, Rab8 is likely to represent an important player in the pathophysiology of atherosclerosis.
In Tangier disease cells as well as in macrophage foam cells, most of the cholesterol accumulates as cholesteryl esters in lipid droplets, which helps to prevent the accumulation of excess unesterified cholesterol. 26 Therefore, it is worth noting that we found Rab8 overexpression to effectively reduce the cholesteryl ester stores in foam cells. Because Rab8 helps to shunt endocytosed cholesterol for efflux, less cholesterol might be available for storage in lipid droplets as cholesteryl esters. Rab8 overexpression might also more directly facilitate the mobilization of lipid droplet cholesterol, eg, via the Golgi apparatus. These scenarios are not mutually exclusive, ie, both the endosomal and lipid droplet cholesterol pools may serve as sources for ABCA1mediated, Rab8-stimulated cholesterol efflux.
An interesting question arising from the present study is how Rab8 controls the cell surface accessibility of ABCA1 and cholesterol removal from endosomal circuits to apoA-I. One possibility is that the primary effect of Rab8 is the mobilization of endosomal cholesterol, and this affects ABCA1 levels and localization by regulatory mechanisms, such as liver X receptor activation via the generation of oxysterols. However, Rab8 overexpression was found to markedly increase the amount of ABCA1 protein without a corresponding upregulation of the mRNA, rather arguing for a more direct posttranslational role for Rab8. It seems likely that Rab8 is involved in the transport/recycling of ABCA1 to the cell surface. Supporting this view, Rab8 siRNA decreased the proportion of ABCA1 at the cell surface and caused the retention of ABCA1-GFP in ␤1 integrin containing intracellular tubules and TfR-positive recycling compartment.
ABCA1-GFP has been localized to endosomes and the plasma membrane 25 but how ABCA1 cycles between them is not clear. The colocalization of ABCA1-GFP with ␤1 integrin in control and Rab8-depleted cells suggests that ABCA1 recycles in part along the same route as ␤1 integrin. Rab8 depletion also caused some ABCA1-GFP to redistribute to a perinuclear TfR-positive recycling compartment. Because ABCA1-GFP does not normally reside in TfR-positive vesicles, 25 this reinforces the idea of altered ABCA1 trafficking on Rab8 depletion. Of note, the transport routes of ␤1 integrin and TfR are related as the proteins partially recycle via the same compartments and are in part regulated by the same GTPases. 27 Moreover, syntaxin-13, which has been shown to interact with ABCA1, 28 also regulates TfR recycling. 29 In several cell types, Rab8 regulates cell shape, particularly the formation of specialized cell surface extensions that rely on coordinated cytoskeletal organization and membrane transport. 12, 13, 15, 16 We found that on challenging with modified LDL and apoA-I, macrophages elongated and developed a migratory phenotype with a leading edge and a tracking tail. Also, cell motility increased (our unpublished observations). Moreover, Rab8, ABCA1, and ␤1 integrin were concentrated at the leading edge of cells. Together with the data on cholesterol efflux, our results suggest that membrane protru- sions at the leading edge may function as preferential plasma membrane domains for cholesterol efflux to apoA-I. This agrees with earlier studies in which ABCA1 was found to interact with scaffolding molecules linking to the cortical actin cytoskeleton 30, 31 or the small GTPase Cdc42 that regulates the formation of filopodia. 32, 33 Considering the involvement of Rab8 in cytoskeletal regulation, it is also conceivable that Rab8 contributes to the stabilization of ABCA1 at the plasma membrane.
In summary, our results indicate that Rab8 is one of the intracellular regulators that promote ABCA1 plasma membrane localization and govern the delivery of cholesterol to apoA-I in macrophages. Interestingly, Rab8 has also been reported to regulate the exocytic delivery of MT1-matrix metalloproteinase during cell invasion, 34 a process that is critical for the infiltration of macrophages into atherosclerotic lesions. 20 Given the dual role for Rab8 in matrix metalloproteinase release and ABCA1-mediated cholesterol efflux by tissue-infiltrating cells, it seems plausible that these processes function in a coordinated fashion to facilitate cholesterol scavenging and efflux in the arterial wall.
